vs

Side-by-side financial comparison of Amrize Ltd (AMRZ) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.7B, roughly 1.2× Amrize Ltd). Amrize Ltd runs the higher net margin — 14.8% vs 13.9%, a 0.9% gap on every dollar of revenue. On growth, Amrize Ltd posted the faster year-over-year revenue change (6.6% vs 4.1%). Amrize Ltd produced more free cash flow last quarter ($669.0M vs $602.0M).

Holcim is a Swiss-based global building materials and aggregates flagship division of the Holcim Group. The original company was merged on 10 July 2015 with Lafarge to form LafargeHolcim as the new company and renamed to Holcim Group in 2021. The Holcim brand remained active within the group when the merger was completed.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

AMRZ vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.2× larger
EMR
$4.3B
$3.7B
AMRZ
Growing faster (revenue YoY)
AMRZ
AMRZ
+2.5% gap
AMRZ
6.6%
4.1%
EMR
Higher net margin
AMRZ
AMRZ
0.9% more per $
AMRZ
14.8%
13.9%
EMR
More free cash flow
AMRZ
AMRZ
$67.0M more FCF
AMRZ
$669.0M
$602.0M
EMR

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AMRZ
AMRZ
EMR
EMR
Revenue
$3.7B
$4.3B
Net Profit
$545.0M
$605.0M
Gross Margin
29.6%
53.2%
Operating Margin
21.2%
17.8%
Net Margin
14.8%
13.9%
Revenue YoY
6.6%
4.1%
Net Profit YoY
-1.4%
3.4%
EPS (diluted)
$0.98
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRZ
AMRZ
EMR
EMR
Q4 25
$4.3B
Q3 25
$3.7B
$4.9B
Q2 25
$3.2B
$4.6B
Q1 25
$4.4B
Q4 24
$4.2B
Q3 24
$3.4B
$4.6B
Q2 24
$3.2B
$4.4B
Q1 24
$4.4B
Net Profit
AMRZ
AMRZ
EMR
EMR
Q4 25
$605.0M
Q3 25
$545.0M
$637.0M
Q2 25
$429.0M
$586.0M
Q1 25
$485.0M
Q4 24
$585.0M
Q3 24
$553.0M
$996.0M
Q2 24
$474.0M
$329.0M
Q1 24
$501.0M
Gross Margin
AMRZ
AMRZ
EMR
EMR
Q4 25
53.2%
Q3 25
29.6%
51.9%
Q2 25
30.0%
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
30.2%
51.3%
Q2 24
30.2%
52.8%
Q1 24
52.2%
Operating Margin
AMRZ
AMRZ
EMR
EMR
Q4 25
17.8%
Q3 25
21.2%
16.4%
Q2 25
20.8%
16.1%
Q1 25
14.2%
Q4 24
18.6%
Q3 24
24.5%
14.7%
Q2 24
23.3%
10.4%
Q1 24
16.2%
Net Margin
AMRZ
AMRZ
EMR
EMR
Q4 25
13.9%
Q3 25
14.8%
13.1%
Q2 25
13.3%
12.9%
Q1 25
10.9%
Q4 24
14.0%
Q3 24
16.0%
21.6%
Q2 24
14.6%
7.5%
Q1 24
11.4%
EPS (diluted)
AMRZ
AMRZ
EMR
EMR
Q4 25
$1.07
Q3 25
$0.98
$1.12
Q2 25
$0.78
$1.04
Q1 25
$0.86
Q4 24
$1.02
Q3 24
$1.00
$1.74
Q2 24
$0.86
$0.57
Q1 24
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRZ
AMRZ
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$826.0M
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$12.9B
$20.3B
Total Assets
$24.0B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRZ
AMRZ
EMR
EMR
Q4 25
Q3 25
$826.0M
Q2 25
$601.0M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
AMRZ
AMRZ
EMR
EMR
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
AMRZ
AMRZ
EMR
EMR
Q4 25
$20.3B
Q3 25
$12.9B
$20.3B
Q2 25
$12.4B
$19.9B
Q1 25
$19.2B
Q4 24
$20.5B
Q3 24
$9.8B
$21.6B
Q2 24
$9.3B
$20.8B
Q1 24
$20.9B
Total Assets
AMRZ
AMRZ
EMR
EMR
Q4 25
$41.9B
Q3 25
$24.0B
$42.0B
Q2 25
$23.8B
$42.5B
Q1 25
$42.0B
Q4 24
$42.6B
Q3 24
$44.2B
Q2 24
$45.6B
Q1 24
$46.4B
Debt / Equity
AMRZ
AMRZ
EMR
EMR
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRZ
AMRZ
EMR
EMR
Operating Cash FlowLast quarter
$854.0M
$699.0M
Free Cash FlowOCF − Capex
$669.0M
$602.0M
FCF MarginFCF / Revenue
18.2%
13.9%
Capex IntensityCapex / Revenue
5.0%
2.2%
Cash ConversionOCF / Net Profit
1.57×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRZ
AMRZ
EMR
EMR
Q4 25
$699.0M
Q3 25
$854.0M
$3.1B
Q2 25
$1.1B
Q1 25
$241.0M
Q4 24
$777.0M
Q3 24
$3.3B
Q2 24
$1.1B
Q1 24
$743.0M
Free Cash Flow
AMRZ
AMRZ
EMR
EMR
Q4 25
$602.0M
Q3 25
$669.0M
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$998.0M
Q1 24
$661.0M
FCF Margin
AMRZ
AMRZ
EMR
EMR
Q4 25
13.9%
Q3 25
18.2%
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
22.8%
Q1 24
15.1%
Capex Intensity
AMRZ
AMRZ
EMR
EMR
Q4 25
2.2%
Q3 25
5.0%
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
2.1%
Q1 24
1.9%
Cash Conversion
AMRZ
AMRZ
EMR
EMR
Q4 25
1.16×
Q3 25
1.57×
4.86×
Q2 25
1.83×
Q1 25
0.50×
Q4 24
1.33×
Q3 24
3.35×
Q2 24
3.31×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRZ
AMRZ

Building Materials$2.8B75%
Building Envelope$901.0M25%
Equity Method Investee$5.0M0%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons